Sumitomo Chemical India Share Price
Sector: Chemical Manufacturing
521.05 +5.85 (1.14%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
510.60
Today’s High
530.00
52 Week Low
446.70
52 Week High
628.00
522.70 +7.25 (1.41%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
515.00
Today’s High
530.00
52 Week Low
446.20
52 Week High
628.30
Key Metrics
- Market Cap (In Cr) 25967.67
- Beta 0.37
- Div. Yield (%) 0.23
- P/B 8.99
- TTM P/E 55.22
- Sector P/E 17.63
- D/E 0
- Open Price 510.6
- Prev Close 515.2
Sumitomo Chemical India Analysis
Price Analysis
-
1 Week6.25%
-
3 Months-6.55%
-
6 Month0.75%
-
YTD-1.88%
-
1 Year9.35%
Risk Meter
- 33% Low risk
- 33% Moderate risk
- 33% Balanced Risk
- 33% High risk
- 33% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 4
- 4
- Buy
- 2
- 2
- 2
- 2
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 1
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 6
- 6
- 7
- 7
Sumitomo Chemical India News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 20 Jun 2025Gillette India, KEC, Vadilal to PTC India: Seven stocks that declared dividend
2 min read . 27 May 2025Q4 results today: GIC, Aurobindo Pharma, Sumitomo Chemical, Nazara Tech, more
1 min read . 26 May 2025Recommended stocks to buy today: Top stock picks by market experts for 19 May
11 min read . 19 May 2025Sumitomo Chemical India Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 3148.52
- Selling/ General/ Admin Expenses Total
- 264.66
- Depreciation/ Amortization
- 66.06
- Other Operating Expenses Total
- 392.89
- Total Operating Expense
- 2582.53
- Operating Income
- 566
- Net Income Before Taxes
- 680.24
- Net Income
- 505.5
- Diluted Normalized EPS
- 10.13
- Period
- 2025
- Total Assets
- 3964.43
- Total Liabilities
- 1063.28
- Total Equity
- 2901.15
- Tangible Book Valueper Share Common Eq
- 56.39
- Period
- 2025
- Cashfrom Operating Activities
- 452.73
- Cashfrom Investing Activities
- -392.06
- Cashfrom Financing Activities
- -69.08
- Net Changein Cash
- -8.4
- Period
- 2024
- Total Revenue
- 2843.95
- Selling/ General/ Admin Expenses Total
- 523.38
- Depreciation/ Amortization
- 62.19
- Other Operating Expenses Total
- 26.09
- Total Operating Expense
- 2431.55
- Operating Income
- 412.4
- Net Income Before Taxes
- 502.95
- Net Income
- 369.54
- Diluted Normalized EPS
- 7.4
- Period
- 2024
- Total Assets
- 3313.27
- Total Liabilities
- 871.7
- Total Equity
- 2441.57
- Tangible Book Valueper Share Common Eq
- 47.17
- Period
- 2024
- Cashfrom Operating Activities
- 757.17
- Cashfrom Investing Activities
- -420.38
- Cashfrom Financing Activities
- -337.05
- Net Changein Cash
- -0.26
- Period
- 2023
- Total Revenue
- 3510.97
- Selling/ General/ Admin Expenses Total
- 499.93
- Depreciation/ Amortization
- 51.88
- Other Operating Expenses Total
- 25.33
- Total Operating Expense
- 2896.24
- Operating Income
- 614.73
- Net Income Before Taxes
- 654.18
- Net Income
- 502.21
- Diluted Normalized EPS
- 10.06
- Period
- 2023
- Total Assets
- 3369.11
- Total Liabilities
- 987.33
- Total Equity
- 2381.78
- Tangible Book Valueper Share Common Eq
- 47.29
- Period
- 2023
- Cashfrom Operating Activities
- 389.39
- Cashfrom Investing Activities
- -327.2
- Cashfrom Financing Activities
- -72.55
- Net Changein Cash
- -10.36
- Period
- 2022
- Total Revenue
- 3064.6
- Selling/ General/ Admin Expenses Total
- 475
- Depreciation/ Amortization
- 44.81
- Other Operating Expenses Total
- 35.62
- Total Operating Expense
- 2507.76
- Operating Income
- 556.84
- Net Income Before Taxes
- 575.73
- Net Income
- 423.56
- Diluted Normalized EPS
- 8.48
- Period
- 2022
- Total Assets
- 3009.63
- Total Liabilities
- 1082.42
- Total Equity
- 1927.21
- Tangible Book Valueper Share Common Eq
- 38.24
- Period
- 2022
- Cashfrom Operating Activities
- 221.78
- Cashfrom Investing Activities
- -290.2
- Cashfrom Financing Activities
- -62.64
- Net Changein Cash
- -131.06
- Period
- 2021
- Total Revenue
- 2644.91
- Selling/ General/ Admin Expenses Total
- 442.91
- Depreciation/ Amortization
- 46.58
- Other Operating Expenses Total
- 29.17
- Total Operating Expense
- 2201.35
- Operating Income
- 443.56
- Net Income Before Taxes
- 453.3
- Net Income
- 345.31
- Diluted Normalized EPS
- 6.92
- Period
- 2021
- Total Assets
- 2671.93
- Total Liabilities
- 1130.73
- Total Equity
- 1541.2
- Tangible Book Valueper Share Common Eq
- 30.66
- Period
- 2021
- Cashfrom Operating Activities
- 425.41
- Cashfrom Investing Activities
- -282.66
- Cashfrom Financing Activities
- -47.06
- Net Changein Cash
- 95.69
- Period
- 2020
- Total Revenue
- 2424.75
- Selling/ General/ Admin Expenses Total
- 417.57
- Depreciation/ Amortization
- 40.97
- Other Operating Expenses Total
- 33.55
- Total Operating Expense
- 2158.75
- Operating Income
- 266
- Net Income Before Taxes
- 266.52
- Net Income
- 204.7
- Diluted Normalized EPS
- 4.58
- Period
- 2020
- Total Assets
- 2106.16
- Total Liabilities
- 884.41
- Total Equity
- 1221.75
- Tangible Book Valueper Share Common Eq
- 24.37
- Period
- 2020
- Cashfrom Operating Activities
- 221.4
- Cashfrom Investing Activities
- -117.86
- Cashfrom Financing Activities
- -61.39
- Net Changein Cash
- 42.15
- Period
- 2019
- Total Revenue
- 2211.74
- Selling/ General/ Admin Expenses Total
- 415.69
- Depreciation/ Amortization
- 27.8
- Other Operating Expenses Total
- 20.7
- Total Operating Expense
- 1949.87
- Operating Income
- 261.88
- Net Income Before Taxes
- 259.84
- Net Income
- 165.8
- Diluted Normalized EPS
- 3.32
- Period
- 2019
- Total Assets
- 1859.97
- Total Liabilities
- 811.57
- Total Equity
- 1048.4
- Tangible Book Valueper Share Common Eq
- 20.86
- Period
- 2019
- Cashfrom Operating Activities
- 77.69
- Cashfrom Investing Activities
- -35.32
- Cashfrom Financing Activities
- -65.45
- Net Changein Cash
- -23.08
- Period
- 2025-03-31
- Total Revenue
- 679.42
- Selling/ General/ Admin Expenses Total
- 64.72
- Depreciation/ Amortization
- 16.42
- Other Operating Expenses Total
- 87.68
- Total Operating Expense
- 576.28
- Operating Income
- 103.15
- Net Income Before Taxes
- 133.11
- Net Income
- 99.58
- Diluted Normalized EPS
- 2
- Period
- 2025-03-31
- Total Assets
- 3964.43
- Total Liabilities
- 1063.28
- Total Equity
- 2901.15
- Tangible Book Valueper Share Common Eq
- 56.39
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 452.73
- Cashfrom Investing Activities
- -392.06
- Cashfrom Financing Activities
- -69.08
- Net Changein Cash
- -8.4
- Period
- 2024-12-31
- Total Revenue
- 641.92
- Selling/ General/ Admin Expenses Total
- 68.34
- Depreciation/ Amortization
- 19.06
- Other Operating Expenses Total
- 96.08
- Total Operating Expense
- 554.87
- Operating Income
- 87.05
- Net Income Before Taxes
- 116.5
- Net Income
- 86.95
- Diluted Normalized EPS
- 1.74
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 988.3
- Selling/ General/ Admin Expenses Total
- 66.05
- Depreciation/ Amortization
- 15.71
- Other Operating Expenses Total
- 109.34
- Total Operating Expense
- 758.74
- Operating Income
- 229.56
- Net Income Before Taxes
- 259.57
- Net Income
- 192.29
- Diluted Normalized EPS
- 3.85
- Period
- 2024-09-30
- Total Assets
- 3842.61
- Total Liabilities
- 1129.11
- Total Equity
- 2713.5
- Tangible Book Valueper Share Common Eq
- 52.64
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 358.19
- Cashfrom Investing Activities
- -298.57
- Cashfrom Financing Activities
- -53.17
- Net Changein Cash
- 6.46
- Period
- 2024-06-30
- Total Revenue
- 838.89
- Selling/ General/ Admin Expenses Total
- 65.55
- Depreciation/ Amortization
- 14.86
- Other Operating Expenses Total
- 99.79
- Total Operating Expense
- 692.65
- Operating Income
- 146.23
- Net Income Before Taxes
- 171.06
- Net Income
- 126.68
- Diluted Normalized EPS
- 2.54
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 674.2
- Selling/ General/ Admin Expenses Total
- 59.18
- Depreciation/ Amortization
- 16.77
- Other Operating Expenses Total
- 82.12
- Total Operating Expense
- 550.8
- Operating Income
- 123.41
- Net Income Before Taxes
- 148.8
- Net Income
- 109.7
- Diluted Normalized EPS
- 2.19
- Period
- 2024-03-31
- Total Assets
- 3313.27
- Total Liabilities
- 871.7
- Total Equity
- 2441.57
- Tangible Book Valueper Share Common Eq
- 47.17
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 757.17
- Cashfrom Investing Activities
- -420.38
- Cashfrom Financing Activities
- -337.05
- Net Changein Cash
- -0.26
- Period
- 2023-12-31
- Total Revenue
- 542.02
- Selling/ General/ Admin Expenses Total
- 53.9
- Depreciation/ Amortization
- 16.12
- Other Operating Expenses Total
- 95.78
- Total Operating Expense
- 492.32
- Operating Income
- 49.7
- Net Income Before Taxes
- 75.35
- Net Income
- 54.71
- Diluted Normalized EPS
- 1.1
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Sumitomo Chemical India Technical
Moving Average
SMA
- 5 Day507.59
- 10 Day501.96
- 20 Day505.5
- 50 Day518.34
- 100 Day514.04
- 300 Day524.64
Sumitomo Chemical India Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Deepak Nitrite
- 1981.25
- 12.25
- 0.62
- 3168.65
- 1780.5
- 27084.77
- Bayer Cropscience
- 6065
- 153.05
- 2.59
- 7189.9
- 4220.05
- 27296.39
- Sumitomo Chemical India
- 521.05
- 5.85
- 1.14
- 628
- 446.7
- 25967.67
- Tata Chemicals
- 934.6
- -0.45
- -0.05
- 1244.7
- 756.45
- 23836.29
- Navin Fluorine International
- 4820.6
- 138.95
- 2.97
- 4798
- 3164
- 23905.48
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Deepak Nitrite
- 38.53
- 4.99
- 23.28
- 11.97
- Bayer Cropscience
- 46.77
- 9.32
- 24.01
- 12.97
- Sumitomo Chemical India
- 50.88
- 8.87
- 20.73
- 14.12
- Tata Chemicals
- 82.45
- 1.1
- 4.72
- 7.28
- Navin Fluorine International
- 80.57
- 8.85
- 14.45
- 15.83
Sumitomo Chemical India Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 26-May-25
- Audited Results & Final Dividend
- 27-Jan-25
- Quarterly Results
- 28-Oct-24
- Quarterly Results
- 27-Jul-24
- Quarterly Results
- 27-May-24
- Audited Results & Final Dividend
- 01-Feb-24
- Quarterly Results
- 27-Oct-23
- Quarterly Results
- 31-Jul-23
- Quarterly Results
- 18-May-23
- Audited Results & Final Dividend
- 03-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 04-Aug-25
- 26-May-25
- AGM
- 30-Jul-24
- 27-May-24
- AGM
- 28-Jul-23
- 18-May-23
- AGM
- 29-Jul-22
- 05-Jul-22
- AGM
- 30-Jul-21
- 05-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 26-May-25
- -
- -
- 1.2
- 27-May-24
- 19-Jul-24
- 19-Jul-24
- 0.9
- 09-Feb-24
- 14-Feb-24
- 14-Feb-24
- 5
- 09-Feb-24
- 14-Feb-24
- 14-Feb-24
- 5
- 18-May-23
- 21-Jul-23
- 21-Jul-23
- 1.2
- 27-May-22
- 22-Jul-22
- 21-Jul-22
- 1
- 28-May-21
- 23-Jul-21
- 22-Jul-21
- 0.8


